ENVALITH
株式会社フェニックスバイオ logo

PhoenixBio Co.,Ltd.

6190Growth MarketServices

株式会社フェニックスバイオ logo
PhoenixBio Co.,Ltd.6190
Reference Indicators

Market Cap

14¥100M

P/E (Forecast)

P/B

0.9x

Dividend Yield (Forecast)

0.00%

ROE

8.7%

EV/EBITDA

5.1x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
1,3242,1241,7151,5411,565
Cost of Sales
597567520423364
Gross Profit
7271,5561,1951,1171,200
SG&A Expenses
8951,0481,1831,2591,117
Operating Income
-16750811-14282
Non-operating Income
4015422053
Non-operating Expenses
1129345
Ordinary Income
-12751143-155131
Extraordinary Income
17370
Extraordinary Losses
265013150
Pre-tax Income
-39351059-432131
Income Taxes
-51733166
Net Income
-38749326-448125
EBITDA
-8153236-113116
Gross Margin
54.9%73.3%69.7%72.5%76.7%
Operating Margin
-12.7%23.9%0.6%-9.2%5.3%
ROA
-17.0%16.3%1.0%-19.6%5.7%
ROE
-46.0%42.4%1.6%-33.8%8.7%